reference standard is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-03. Numbers and descriptions here follow the published literature rather than marketing material.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved as a medicine in major jurisdictions | Sold as a research chemical; legal status varies |
| Anti-doping status | Prohibited by the World Anti-Doping Agency | Listed under non-approved substances or related category |
| Typical analytical method | LC-MS/MS | Used for detection and confirmation in biological samples |
| Storage temperature | −20 °C or lower for solid | Desiccated and protected from light |
| Common solution solvents | DMSO; ethanol | Aqueous solubility is limited |
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ, also called NR1D1 and NR1D2. These receptors help regulate circadian rhythms and metabolic gene programs. The compound was developed for laboratory research, not as an approved therapeutic. Its identity is distinct from steroid hormones and selective androgen receptor modulators. Scientific interest centers on how REV-ERB activation changes gene expression in cells and animal models.
At the molecular level, SR9009 binds the ligand-binding domain of REV-ERB and strengthens recruitment of corepressor proteins such as NCoR and HDAC3. This increases repression of target genes, including Bmal1 and other clock-controlled and metabolic genes. In rodent studies, such changes have been linked to altered lipid handling, glucose metabolism, and energy expenditure. The precise chain of events between receptor binding and whole-body effects remains an active area of research. Findings in animals do not automatically translate to humans.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
In this study, the UK school children had a low baseline cellular immunity to mycobacteria which was increased by BCG; in contrast, the Malawi school children had a high baseline cellular immunity to mycobacteria and this was not significantly increased by BCG. Whether this natural immune response is protective is not known. An alternative explanation is suggested by mouse studies; immunity against mycobacteria stops BCG from replicating and so stops it from producing an immune response. This is called the block hypothesis. Interference by concurrent parasitic infection In another hypothesis, simultaneous infection with parasites such as helminthiasis changes the immune response to BCG, making it less effective. As Th1 response is required for an effective immune response to tuberculous infection, but concurrent infection with various parasites produces a simultaneous Th2 response, which blunts the effect of BCG.
Taxidermy is the art of preserving an animal's body by mounting (over an armature) or stuffing, for the purpose of display or study. Animals are often, but not always, portrayed in a lifelike state. The word taxidermy describes the process of preserving the animal, but the word is also used to describe the end product, which are called taxidermy mounts or referred to simply as "taxidermy". The word taxidermy is derived from the Ancient Greek words τάξις taxis (order, arrangement) and δέρμα derma (skin). Thus taxidermy translates to "arrangement of skin". Taxidermy is practiced primarily on vertebrates (mammals, birds, fish, reptiles, and less commonly on amphibians) but can also be done to larger insects and arachnids under some circumstances. Taxidermy takes on a number of forms and purposes including hunting trophies and natural history museum displays. Unlike meat harvesting, taxidermy does not require killing an animal that could have otherwise remained alive. Museums use taxidermy as a method to record species, including those that are extinct and threatened, in the form of study skins and life-size mounts. Taxidermy is sometimes also used as a means to memorialize pets. A person who practices taxidermy is called a taxidermist. They may practice professionally, catering to museums and sportspeople (hunters and fishers), or as amateurs (hobbyists). A taxidermist is aided by familiarity with anatomy, sculpture, painting, and tanning.
=== Youth === The top three riders in the final results of each World Tour event's young rider classification received points towards the standings. Six points were awarded to first place, four points to second place and two points to third place.
Sources: en.wikipedia.org
=== 5 July === One person was killed in a Russian airstrike in Donetsk Oblast. In Russia, the governor of Rostov Oblast claimed that ten drones were shot down, causing a fire in Rostov-on-Don. The governor of Krasnodar Krai claimed that a child was killed in a drone attack in Primorsko-Akhtarsk.
== References == 97.^ Jayesh Kakar https://savelegs.com/negative-pressure-wound-therapy-in-foot-infections-in-diabetics-effect-on-duration-of-antibiotic-therapy-method-negative-pressure-wound-therapy-has-be/External links
==== Multi-printhead and multi-material ==== In multi-printhead and multi-material printing, multiple ingredients are printed at the same time or in succession. There are different ways to support multi-material printing. In one instance, multiple printheads are used to print multiple materials/ingredients, as this can speed up production, efficiency, and lead to interesting design patterns. In another instance, there is one printhead, and when a different ingredient is required, the printer exchanges the material being printed. Multiple materials/ingredients equates to a more diverse range of meals available to print, a broader nutritional range, and is quite common for food printers.
Sources: en.wikipedia.org
The civil status records from 1860 to 1902 and the index of reconstructed records prior to 1860 (December 15, 2009). The ten-year tables of births, marriages, and deaths from 1903 to 1932; the annual tables of marriages from 1933 to 1939; the annual tables of deaths from 1933 to 1954; and the ten-year tables of marriages and deaths from 1955 to 1974 (January 12, 2016). Birth records from 1903; marriage records from 1903 to 1940. Death records from 1903 to 1986; ten-year tables of deaths from 1975 to 1984. Marriage records from 1941 to 1945; annual tables of deaths for 1985 and 1986. Reconstructed civil status records prior to 1860: Birth records (November 2020). Marriage records (January 2021). Death records (November 2021). Currently, all old Parisian civil records are accessible online.
Salts are characteristically insulators. Although they contain charged atoms or clusters, these materials do not typically conduct electricity to any significant extent when the substance is solid. In order to conduct, the charged particles must be mobile rather than stationary in a crystal lattice. This is achieved to some degree at high temperatures when the defect concentration increases the ionic mobility and solid state ionic conductivity is observed. When the salts are dissolved in a liquid or are melted into a liquid, they can conduct electricity because the ions become completely mobile. For this reason, molten salts and solutions containing dissolved salts (e.g., sodium chloride in water) can be used as electrolytes. This conductivity gain upon dissolving or melting is sometimes used as a defining characteristic of salts. In some unusual salts: fast-ion conductors, and ionic glasses, one or more of the ionic components has a significant mobility, allowing conductivity even while the material as a whole remains solid. This is often highly temperature dependent, and may be the result of either a phase change or a high defect concentration. These materials are used in all solid-state supercapacitors, batteries, and fuel cells, and in various kinds of chemical sensors.
== Naming conventions == Before reunification, Germany was divided between the Bundesrepublik Deutschland (Federal Republic of Germany; commonly known as West Germany) and the Deutsche Demokratische Republik (DDR; German Democratic Republic; commonly known as East Germany). Reunification was achieved by accession (Beitritt) of the German Democratic Republic to the Federal Republic of Germany, so Bundesrepublik Deutschland became the official name of reunified Germany. In East Germany, the terms Westdeutschland (West Germany) or westdeutsche Bundesrepublik (West German Federal Republic) were preferred during the 1950s and 1960s. This changed under its constitutional amendment in 1974, when the idea of a single German nation was abandoned by East Germany. As a result, it officially considered West Germans and West Berliners as foreigners. The initialism BRD (FRG in English) began to prevail in East German usage in the early 1970s, beginning in the newspaper Neues Deutschland. Other Eastern Bloc nations soon followed suit. In 1965, the West German Federal Minister of All-German Affairs, Erich Mende, had issued the "Directives for the Appellation of Germany", recommending avoiding the initialism BRD. On 31 May 1974, the heads of West German federal and state governments recommended always using the full name in official publications. From then on, West German sources avoided the abbreviated form, with the exception of left-leaning organisations which embraced it.
Sources: en.wikipedia.org
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.
Laboratories typically use LC-MS/MS to detect SR9009 and related compounds in urine or blood. The method is sensitive but depends on sample collection timing. Confirmatory analysis follows quality-control procedures.
Solid material is generally kept cold, dry, and protected from light. Solutions are often stored in sealed containers at low temperature. Stability beyond recommended periods is not well documented.
It is a synthetic research compound that activates REV-ERB nuclear receptors. It is not an approved drug or dietary supplement. Most information comes from cell and animal studies.